FDA Approves Prevnar 13 Pneumococcal Disease Vaccine
Links shared publicly online about this topic.
- 1,355total visits
FDA Approves Prevnar 13 Pneumococcal Disease Vaccine
View full resource at drugs.com
Tags: Vaccination, Pneumococcal Disease, Pneumococcal Vaccine, Disease and Condition, FDA, Vaccine, Prevnar
Most Recently Shared on February 26, 2010 at 1:03 am By:
FDA Approves Prevnar 13 Pneumococcal Disease Vaccine - http://bit.ly/cx9k4D
FDA Greenlights Pneumonia Vaccine
medicalnewstoday.com — “The FDA has approved Prevnar 13, for use on people over 50. Prevnar 13 is a pneumococcal 13-valent conjugate vaccine, that can prevent pneumonia and disease caused by the bacterium, Streptococ” View full resource at medicalnewstoday.com
Most Recently Shared on January 2, 2012 at 6:05 pm By:
MedicalNewsToday: FDA Greenlights Pneumonia Vaccine http://t.co/CVwo11L4 Full http://t.co/XexlS93r
FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults
news-medical.net — “Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted approval of the Company's pneumococcal conjugate vaccine Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) as a single dose for use in adults.” View full resource at news-medical.net
Most Recently Shared on December 31, 2011 at 9:55 am By:
Meningitis News: FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults: Pf... http://t.co/4eorFS2i
Medical News: Kids' Pneumococcal Vaccine Elicits Response in Adults - in Infectious Disease, Vaccines from MedPage Today
medpagetoday.com — “The pneumococcal 13-valent conjugate vaccine (Prevnar 13) -- which is approved for infants and children younger than 6 -- was immunogenic in adults 50 and older, Pfizer announced.” View full resource at medpagetoday.com
Most Recently Shared on May 9, 2011 at 9:35 pm By:
Patricia Grace Eldercare Expert
Kids' Pneumococcal Vaccine Elicits Response in Adults: (MedPage Today) -- The pneumococcal 13-valent conjugate v... http://bit.ly/ml05VC
Supplemental NDA submitted for Prevnar 13 in older adults - MPR
empr.com — “Pfizer announced that it has submitted a supplemental NDA (sNDA) to the FDA to expand the use of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.” View full resource at empr.com
Most Recently Shared on December 23, 2010 at 6:23 pm By:
MPR News: Supplemental NDA submitted for Prevnar 13 in older adults: Pfizer announced that it has submitted a su... http://bit.ly/f9E30H
Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease
news-medical.net — “Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.” View full resource at news-medical.net
Most Recently Shared on December 23, 2010 at 10:36 am By:
Meningitis News: Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease: Pfiz... http://bit.ly/eq2rKO
Symposier - New Pneumococcal Vaccine for Children
symposier.com — “Uploaded and Shared in Youtube by: USFoodandDrugAdmin FDA has approved a new pneumococcal vaccine that provides broader protection for infants and young children ages six weeks through five years. The new vaccine, called Prevnar 13, is effective against 13 serotypes of the bacterium Streptococcus pneumoniae. It will replace Prevnar, which was effective against seven serotypes. Prevnar 13 is approved to prevent invasive pneumococcal disease, including bacterial meningitis and bacteremia, caused b” View full resource at symposier.com
Most Recently Shared on May 21, 2010 at 6:04 pm By:
FDA - New Pneumococcal Vaccine for Children. http://bit.ly/cML6lF
PCV13 vaccine may have big effect among young children - Related Stories - AAP SmartBrief
smartbrief.com — “A CDC report said a recently approved broader pneumococcal vaccine could significantly reduce the rate of disease in young children. The FDA approved the PCV13 vaccine last month, and it covers pneumococcal strains that were responsible for 64% of pneumococcal cases in children under age 5 in 2007.” View full resource at smartbrief.com
Most Recently Shared on March 12, 2010 at 8:04 pm By:
Clara Song Pediatrician, Physician, and Doctor
PCV13 vaccine may have big effect among young children http://sbne.ws/r/42Wj
Otitis Media: eMedicine Pediatrics: Surgery
emedicine.medscape.com — “Overview: Otitis media (OM) is the second most common disease of childhood, after upper respiratory infection (URI). OM is also the most common cause for childhood visits to a physician's office. Annually, an estimated 16 million office ...” View full resource at emedicine.medscape.com
Most Recently Shared on March 5, 2010 at 10:41 pm By:
Medscape Pediatrics Health Site and Pediatrics
Pneumococcal vaccine valent-13 (Prevnar 13) approved. See the eMedicine topic Otitis Media for details. http://bit.ly/aULAUV
Pfizer Receives FDA Approval For Prevnar 13™ For The Prevention Of Invasive Pneumococcal Disease In Infants And Young Children
medicalnewstoday.com — “Pfizer Inc. (NYSE:PFE) announced today that the United States Food and Drug Administration (FDA) has granted approval for Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CR” View full resource at medicalnewstoday.com
Most Recently Shared on February 26, 2010 at 2:16 pm By:
MNT Pediatrics News Pediatrics and Health News
Pfizer Receives FDA Approval For Prevnar 13™ For The Prevention Of Invasive Pneumococcal Disease In Infants And ... http://mnt.to/3y8Z
FDA Approves Pneumococcal Disease Vaccine With Broader Protection
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor” View full resource at medicalnewstoday.com
Most Recently Shared on February 25, 2010 at 2:55 pm By:
FDA Approves Pneumococcal Disease Vaccine With Broader Protection The U.S. Food and Drug Administration approved Prev.. http://bit.ly/adkhzF
FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine
news-medical.net — “Pfizer Inc. announced today that the United States Food and Drug Administration has granted approval for Prevnar 13" (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company's 13-valent pneumococcal conjugate vaccine.” View full resource at news-medical.net
Most Recently Shared on February 25, 2010 at 5:38 am By:
FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine: Pfizer Inc. announced today that the United State... http://bit.ly/bOQF86
Medical News: New Version of Pneumococcal Vaccine Gets Okay - in Product Alert, Devices and Vaccines from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a 13-valent version of the pneumococcal conjugate vaccine Prevnar for use in pediatric patients 6 months to 5 years old.” View full resource at medpagetoday.com
Most Recently Shared on February 24, 2010 at 8:42 pm By:
New Version of Pneumococcal Vaccine Gets Okay WASHINGTON (MedPage Today) -- The FDA has approved a 13-valent version .. http://bit.ly/amhGBA
FDA approves Prevnar 13; ACIP issues recommendations for use
pediatricsupersite.com — “The FDA today approved Pfizer’s Prevnar 13, indicated for the active immunization of children to prevent invasive disease caused by Strepto” View full resource at pediatricsupersite.com
Most Recently Shared on February 24, 2010 at 8:35 pm By:
Pediatric SuperSite Health Site
FDA approves Prevnar 13; ACIP issues recommendations for use: http://ow.ly/1aVtz
FDA approves new pneumonia vaccine with wider reach - Los Angeles Times
articles.latimes.com — “The Food and Drug Administration on Wednesday approved a new pneumococcal vaccine that protects against more strains of bacteria than the existing one and is expected to produce a sharp reduction in” View full resource at articles.latimes.com
Most Recently Shared on February 24, 2010 at 7:18 pm By:
FDA approves new pneumonia vaccine with wider reach: Prevnar 13 protects against more strains of bacteria than the... http://bit.ly/a6bcM6
Advertisement
